1. A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat

   • G. Storm
   • Q. G. C. M. van Hoesel
   • F. C. Hillen

   Original Articles Pages: 341 - 348

2. Modulation of the antineoplastic efficacy of mitomycin C by dicoumarol in vivo

   • Sara Rockwell
   • Susan R. Keyes
   • Alan C. Sartorelli

   Original Articles Pages: 349 - 353

3. Metabolism and pharmacokinetics of p-(3,3-dimethyl-1-triazeno) benzoic acid in M5076 sarcoma-bearing mice

   • Emilio Benfenati
   • Pierluigi Farina
   • Maurizio D'Incalci

   Original Articles Pages: 354 - 358

4. Two antiemetic regimens do not impair chemical xenogenization induced in vivo by 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide

   • Paola Ballerini
   • Annibale Franchi
   • Enzo Bonmassar

   Original Articles Pages: 359 - 362

5. Factors causing dose variability in drug administration

   • Romano Demicheli
   • Antonio Jirillo
   • Mario Balli

   Original Articles Pages: 363 - 366

6. Reversal of multidrug resistance by new dihydropyridines with lower calcium antagonistic activity

   • Tomoko Yoshinari
   • Yoshikazu Iwasawa
   • Akira Okura

   Original Articles Pages: 367 - 370

7. Clinical pharmacology of N⁴-palmitoyl-1-β-d-arabinofuranosylcytosine in patients with hematologic malignancies

   • Takanori Ueda
   • Toru Nakamura
   • Haruto Uchino

   Original Articles Pages: 371 - 375

8. Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma

   • Stefan S. Bielack
   • Rudolf Erttmann
   • Cooperative Osteosarcoma Study Group COSS)

   Original Articles Pages: 376 - 380

9. Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancer

   • F. Figoli
   • A. Veronesi
   • S. Monfardini

   Original Articles Pages: 381 - 385

10. Pharmacokinetics of high-dose busulfan in children

    • G. Vassal
    • A. Gouyette
    • J. Lemerle

    Original Articles Pages: 386 - 390

11. Phase II clinical trial of high-dose recombinant human tumor necrosis factor

    • H. Lenk
    • St. Tanneberger
    • T. Shiga

    Short Communication Pages: 391 - 392

12. Intralymphatic infusion of interferon in patients with lymph nodal metastases from melanoma of the lower limbs

    • Efisio Sulis
    • Carlo Floris
    • Carlo Massidda

    Short Communication Pages: 393 - 394

13. Ifosfamide cardiotoxicity in humans

    • K. Kandylis
    • M. Vassilomanolakis
    • A. P. Efremidis

    Short Communication Pages: 395 - 396

14. Circadian pharmacokinetics of methotrexate

    • Bridget A. Robinson
    • Evan J. Begg
    • John R. Sharman

    Short Communication Pages: 397 - 399

15. Removal of methotrexate by hemodiafiltration

    • N. Montagne
    • G. Milano
    • M. Schneider

    Letter to the Editors Pages: 400 - 401